Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 118,575 $ 187,288
Short-term restricted cash 1,003 1,051
Accounts receivable, net 85,464 170,619
Inventory 90,343 99,908
Prepaid expenses and other current assets 28,057 29,159
Total current assets 323,442 488,025
Long-term restricted cash 25 17
Property and equipment, net 59,300 66,431
Leased right-of-use assets 18,184 31,264
Intangible assets, net 55,008 73,630
Goodwill 318,588 318,588
Deferred tax assets 68,662 69,493
Other long-term assets 21,430 32,809
Total assets 864,639 1,080,257
Current liabilities:    
Accounts payable 31,378 21,551
Accrued price protection liability 43,401 71,684
Accrued expenses and other current liabilities 87,408 98,468
Accrued compensation 20,097 30,426
Total current liabilities 182,284 222,129
Long-term lease liabilities 16,952 26,243
Long-term debt 122,996 122,375
Other long-term liabilities 26,124 23,245
Total liabilities 348,356 393,992
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 84,613 shares issued and outstanding at December 31, 2024 and 81,818 shares issued and outstanding December 31, 2023 8 8
Additional paid-in capital 886,823 808,575
Accumulated other comprehensive loss (6,823) (3,791)
Accumulated deficit (363,725) (118,527)
Total stockholders’ equity 516,283 686,265
Total liabilities and stockholders’ equity $ 864,639 $ 1,080,257